AVIR Competitors & Alternatives

Compare Atea Pharmaceuticals Inc with similar stocks in the same industry

Biotechnology

AVIR

Main Stock
$5.13
Tradestie Score
67
Market Cap
$228.55M
Revenue Growth
3.0%
Analyst Upside
+83.6%

Top Competitors

232 stocks in Biotechnology
Company Price Market Cap P/E Score Action
SLDB Solid Biosciences Inc. Common Stock
$6.85
$457.09M - 55 Compare
MRVI Maravai LifeSciences Holdings, Inc. Class A Common Stock
$7.90
$454.29M - 38 Compare
RAPT RAPT Therapeutics, Inc. Common Stock
$58.02
$450.49M - 50 Compare
MLTX MoonLake Immunotherapeutics Class A Ordinary Shares
$11.41
$448.32M - 49 Compare
ATXS Astria Therapeutics, Inc. Common Stock
$12.58
$425.52M - 54 Compare
ALMS Alumis Inc. Common Stock
$6.85
$422.50M - 49 Compare
FDMT 4D Molecular Therapeutics, Inc. Common Stock
$13.67
$407.71M - 52 Compare
DSGN Design Therapeutics, Inc. Common Stock
$12.34
$386.68M - 73 Compare
AURA Aura Biosciences, Inc. Common Stock
$6.09
$382.04M - 61 Compare
DRTS Alpha Tau Medical Ltd. Ordinary Shares
$14.77
$371.64M - 51 Compare

Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2834)

232 stocks in this industry